Stockscreener 앱 받기
11.50
4.64%
0.51
시간 외 거래:
11.53
0.03
+0.26%
전일 마감가:
$10.99
열려 있는:
$11.05
하루 거래량:
121.17K
Relative Volume:
0.48
시가총액:
$248.69M
수익:
-
순이익/손실:
$-35.46M
주가수익비율:
-27.26
EPS:
-0.4218
순현금흐름:
$-34.00M
1주 성능:
+10.05%
1개월 성능:
+91.67%
6개월 성능:
+88.52%
1년 성능:
-35.17%
1일 변동 폭
$10.74
$11.59
1주일 범위
$10.21
$11.63
52주 변동 폭
$3.35
$20.30
Contineum Therapeutics Inc Stock (CTNM) Company Profile
명칭
Contineum Therapeutics Inc
전화
(858) 333-5280
주소
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO
CTNM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTNM
Contineum Therapeutics Inc
|
11.50 | 308.18M | 0 | -35.46M | -34.00M | -0.4218 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Contineum Therapeutics Inc Stock (CTNM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-20 | 개시 | William Blair | Outperform |
| 2024-10-22 | 개시 | Robert W. Baird | Outperform |
| 2024-04-30 | 개시 | Morgan Stanley | Overweight |
| 2024-04-30 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-30 | 개시 | Stifel | Buy |
Contineum Therapeutics Inc 주식(CTNM)의 최신 뉴스
What’s the beta of Contineum Therapeutics Inc. stockPortfolio Risk Summary & Low Risk High Reward Trade Ideas - خودرو بانک
What is the next catalyst for Contineum Therapeutics Inc.2025 Fundamental Recap & Stock Portfolio Risk Management - خودرو بانک
What’s the MACD signal for Contineum Therapeutics Inc.Sell Signal & Reliable Intraday Trade Alerts - خودرو بانک
Key metrics from Contineum Therapeutics Inc.’s quarterly dataCPI Data & Long-Term Growth Plans - Newser
Is Contineum Therapeutics Inc. stock ready for a breakoutJuly 2025 Big Picture & Low Risk High Win Rate Stock Picks - Newser
Is Contineum Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - Newser
Is Contineum Therapeutics Inc. gaining market shareJuly 2025 Reactions & Reliable Momentum Entry Alerts - خودرو بانک
Tick level data insight on Contineum Therapeutics Inc. volatilityJuly 2025 EndofMonth & Reliable Price Breakout Alerts - Newser
Can Contineum Therapeutics Inc. stock outperform in a bear marketGap Up & Risk Controlled Daily Trade Plans - خودرو بانک
Using data tools to time your Contineum Therapeutics Inc. exit2025 Top Gainers & Daily Chart Pattern Signal Reports - Newser
Long term hold vs stop loss in Contineum Therapeutics Inc.Earnings Growth Summary & Low Drawdown Investment Ideas - Newser
Analyzing Contineum Therapeutics Inc. with multi timeframe charts2025 Historical Comparison & Long-Term Capital Growth Strategies - Newser
Charles Schwab Investment Management Inc. Has $357,000 Holdings in Contineum Therapeutics, Inc. $CTNM - Defense World
Does Contineum Therapeutics Inc. have pricing powerEarnings Miss & Technical Analysis for Trade Confirmation - خودرو بانک
Chart based exit strategy for Contineum Therapeutics Inc.Weekly Trade Analysis & Risk Controlled Daily Trade Plans - Newser
What indicators show strength in Contineum Therapeutics Inc.July 2025 Rallies & Intraday High Probability Alerts - Newser
Why is Contineum Therapeutics Inc. stock going down2025 Momentum Check & Fast Gaining Stock Reports - khodrobank.com
Is Contineum Therapeutics Inc. trending in predictive chart modelsTrade Risk Summary & Long-Term Capital Growth Ideas - Newser
Price momentum metrics for Contineum Therapeutics Inc. explainedEntry Point & Free Technical Confirmation Trade Alerts - Newser
Can volume confirm reversal in Contineum Therapeutics Inc.Jobs Report & Free Fast Entry Momentum Trade Alerts - Newser
Chart based analysis of Contineum Therapeutics Inc. trendsWeekly Market Summary & Long-Term Growth Stock Strategies - Newser
Contineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Average Rating of “Buy” from Analysts - Defense World
Can machine learning forecast Contineum Therapeutics Inc. recoveryJuly 2025 Selloffs & Expert-Curated Trade Recommendations - Newser
Real time breakdown of Contineum Therapeutics Inc. stock performanceWeekly Risk Summary & Proven Capital Preservation Tips - Newser
Contineum Therapeutics Inc. Bounces Off Moving Average Support getLinesFromResByArray error: size == 0 - sisaissue.com
News impact scoring models applied to Contineum Therapeutics Inc.Trade Volume Summary & Daily Chart Pattern Signals - Newser
How to build a dashboard for Contineum Therapeutics Inc. stock2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Will Contineum Therapeutics Inc. benefit from green energy policies2025 Earnings Impact & Low Drawdown Investment Ideas - خودرو بانک
Will Contineum Therapeutics Inc. benefit from seasonalityJuly 2025 Setups & Growth Oriented Trading Recommendations - خودرو بانک
How liquid is Contineum Therapeutics Inc. stockJuly 2025 Decliners & AI Powered Buy/Sell Recommendations - خودرو بانک
How institutional ownership impacts Contineum Therapeutics Inc. stockTrade Ideas & Daily Oversold Bounce Ideas - Newser
Published on: 2025-08-31 15:27:26 - Newser
What data driven models say about Contineum Therapeutics Inc.’s future2025 Price Targets & Low Risk Growth Stock Ideas - Newser
What machine learning models say about Contineum Therapeutics Inc.July 2025 Summary & Reliable Volume Spike Alerts - Newser
What the charts say about Contineum Therapeutics Inc. today2025 Institutional Moves & AI Powered Market Trend Analysis - Newser
Will Contineum Therapeutics Inc. outperform small cap indexes getLinesFromResByArray error: size == 0 - 시사인 투데이
Using flow based indicators on Contineum Therapeutics Inc.Earnings Recap Report & Fast Moving Stock Watchlists - Newser
Does Contineum Therapeutics Inc. qualify in momentum factor screeningWeekly Trade Summary & Community Consensus Trade Signals - Newser
Contineum Therapeutics Inc (CTNM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):